United States Oncology Biosimilars Market is expected to reach US$ 30.83 Billion by 2033 | DataM Intelligence
… period 2025-2033.
AUSTIN, TX, UNITED STATES, November 4, 2025 / … .
North America, particularly the United States, is witnessing accelerated biosimilar adoption … BioPharma
Sandoz Inc.
Recent Developments:
United States:
In November 2025, the …



